ArticleNature cell biology2020

Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome.

Sergio Martinez-Høyer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.